SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Hyseq??? (HYSQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jongmans who wrote ()4/29/1999 3:58:00 PM
From: John Starks   of 8
 
it all depends on pending litigation with affx. i for one think their sequencing technlogy is potentially powerful, but they may not be able to use it much longer if they lose in court. affx was given a patent on some software that is used to analyze raw data generated by the "sequencing by hybridization" technology that hysq seems to think it owns. affx filed suit against hysq after its software patent award, claiming prior art. my advice on hyseq is to wait for the litigation to end...by that time, ironically, the technology might be obsolete.

--john
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News